Long-Term Everolimus Treatment of Patients with Pancreatic Neuroendocrine Tumors

Publisher： Karger

E-ISSN： 1421-9794|60|3|143-150

ISSN： 0009-3157

Source： Chemotherapy, Vol.60, Iss.3, 2015-03, pp. : 143-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful Everolimus Treatment in a Patient with Advanced Pancreatic Neuroendocrine Tumor Who Developed Everolimus-Induced Interstitial Lung Disease on Two Occasions: A Case Report

By  

Chemotherapy, Vol. 59, Iss. 1, 2013-07 ,pp. : 74-78

Karger

Access to resources Recommend Favorite

Molecular Pathogenesis of Pancreatic Neuroendocrine Tumors

By Ehehalt Florian   Franke Ellen   Pilarsky Christian   Grützmann Robert  

Cancers, Vol. 2, Iss. 4, 2010-11 ,pp. : 1901-1910

MDPI

Access to resources Recommend Favorite

Medical Treatment of Gastroenteropancreatic Neuroendocrine Tumors

By Rinke Anja   Michl Patrick   Gress Thomas  

Cancers, Vol. 4, Iss. 1, 2012-02 ,pp. : 113-129

MDPI

Access to resources Recommend Favorite

Epithelial-Mesenchymal Transition Is a Critical Step in Tumorgenesis of Pancreatic Neuroendocrine Tumors

By Fendrich Volker   Maschuw Katja   Waldmann Jens   Buchholz Malte   Rehm Johannes   Gress Thomas M.   Bartsch Detlef K.   König Alexander  

Cancers, Vol. 4, Iss. 1, 2012-03 ,pp. : 281-294

MDPI

Access to resources Recommend Favorite

Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future

By Ohmoto Akihiro   Rokutan Hirofumi   Yachida Shinichi  

International Journal of Molecular Sciences, Vol. 18, Iss. 1, 2017-01 ,pp. : 143-143

MDPI

Access to resources Recommend Favorite